| Brand Name (active ingredient) | Disease Area | Region/Country of Approval | Owner |
| Chenodeoxycholic acid Leadiant (chenodeoxycholic acid) | Metabolic | Europe, including Switzerland, Israel, Chile | Leadiant Biosciences Ltd. |
| Natulan (procarbazine hydrochoride) | Oncology | Europe | Leadiant Biosciences Ltd. |
Last update: June 2019
Important Note
For patients: if you wish to report an adverse event related to one of our products, please contact your healthcare provider. In addition, you can contact us on safety@leadiantbiosciences.com.
For healthcare professionals: if you wish to report an adverse event related to one of our products, please follow the current regulatory procedure in force in your country or contact us at safety@leadiantbiosciences.com.
If your residence is in the U.S. or Canada, please consult the North American website for details on safety reporting.
